Skip to Content
Opening Bell

Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

1MPast Month3MPast 3 Months6MPast 6 MonthsYTDYear to Date1YPast Year5YPast 5 Years
Selected1M Return
  • MRNAModerna Inc+ 148.05%
  • ABBVAbbVie Inc+ 2.11%

    Partial Period · Jul 31, 2026 — Sep 4, 2026

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

MRNA+ 148.0%ABBV+ 2.1%Tap or hover the chart for values along the way
MetricMRNAABBV
Return
Last Price—256.48
Daily Change—− 1.43%
Period ReturnPast Month
+ 148.05%
+ 2.11%Jul 31, 2026 — Sep 4, 2026
Valuation
Market Cap$58.1 B$453 B
P/E Ratio—72.06
Dividend Yield—4.47%
Net MarginTrailing 12M—9.8%
Risk
Beta—0.20
52-Week Range—190.75 — $267.47

Company

  • MRNAHealth Care · Biotechnology
  • ABBVHealth Care · Biotechnology

Metrics could not be loaded for MRNA: P/E, dividend, beta and the 52-week range stay empty in that column.

FinnhubUpdated 22:51

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.